DNA topoisomerase II inhibitors: new approaches to antitumour therapy

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1341, 2002-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

By Beck W.T. Morgan S.E. Mo Y-Y. Bhat U.G.

Drug Resistance Updates, Vol. 2, Iss. 6, 1999-12 ,pp. : 382-389

Academic Press

Access to resources Recommend Favorite

Dual Topoisomerase I / II Inhibitors in Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 339-353

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of the topoisomerase II inhibitors

By Seiter Karen

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite